Showing results (411-420 of 422) with videos related to
Sort By:
Pageof 43
Nature Communications|November 24, 2023
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signaturesMelanie Schoof, Shweta Godbole, Thomas K Albert, et al.Neurology|August 1, 2007
Location and type of mutation in the LIS1 gene do not predict phenotypic severityG Uyanik, D J Morris-Rosendahl, J Stiegler, et al.Developmental Cell|March 20, 2018
Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH MedulloblastomaDaniel J Merk, Jasmin Ohli, Natalie D Merk, et al.Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.Acta Neuropathologica|July 9, 2024
Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseasesFeizhi Song, Valerija Kovac, Behnam Mohammadi, et al.Nature Medicine|May 17, 2024
A prognostic neural epigenetic signature in high-grade gliomaRichard Drexler, Robin Khatri, Thomas Sauvigny, et al.Nature Communications|July 14, 2026
Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratificationNatalie Berghaus, Arnault Tauziède-Espariat, Thomas Hielscher, et al.Nature Genetics|December 11, 2025
Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer modelsMelanie Schoof, Tuyu Zheng, Martin Sill, et al.Brain Pathology (Zurich, Switzerland)|July 16, 2026
Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reportingKatrin Mauch-Mücke, Christin Siewert, Lora Dimitrova, et al.Acta Neuropathologica|January 24, 2024
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutationSina Neyazi, Erika Yamazawa, Karoline Hack, et al.Pageof 43